ESR1 and breast cancer: The impact of estrogen in breast cancer development has already been established, with findings indicating that patients with high expression of estrogen receptor (ER) have a more favorable prognosis compared to those with ER-negative tumors, which tend to be more aggressive and prone to metastasis [30].